Christine M. Formea

Also affiliated with University of Colorado Denver

Pharmacology, Toxicology and PharmaceuticsMedicineHealth ProfessionsBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update”.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.2008

N/A

4.0DataRank · unranked

173 citations

Allan E. Rettie, Andrew A. Somogyi, Rachel Huddart, Alison E. Fohner, Christine M. Formea +10 more

Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype

Clinical Pharmacology & Therapeutics(2022)10.1002/cpt.2735

N/A

2.2DataRank · unranked

63 citations

Munir Pirmohamed, Andrew A. Somogyi, Sarah Morris, Christine M. Formea, Amanda L. Elchynski +8 more

Considerations When Applying Pharmacogenomics to Your Practice

Mayo Clinic Proceedings(2021)10.1016/j.mayocp.2020.03.011

N/A

1.6DataRank · unranked

40 citations

Christine M. Formea, Eric T. Matey, Jessica A. Wright, Jyothsna Giri, Ann M. Moyer +1 more

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.1830

N/A

0.873DataRank · unranked

337 citations

Craig R. Lee, Li Gong, Kelly E. Caudle, Christine M. Formea, Andrea Gaedigk +4 more

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.2015

N/A

0.858DataRank · unranked

304 citations

Cameron D. Thomas, Julia M. Barbarino, Zeruesenay Desta, Sara L. Van Driest, Nihal El Rouby +15 more

Implementation of preemptive DNA sequence–based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study

Genetics in Medicine(2022)10.1016/j.gim.2022.01.022

N/A

0.637DataRank · unranked

69 citations

Steven E. Scherer, Suzette J. Bielinski, Donna M. Muzny, Leila A. Jones, John L. Black +95 more

The Development of an Infrastructure to Facilitate the Use of Whole Genome Sequencing for Population Health

Journal of Personalized Medicine(2022)10.3390/jpm12111867

N/A

0.425DataRank · unranked

16 citations

Brent Hafen, Sara Graceffo, Nykole Sutherland, Melanie Emmerson, Rachel Palmquist +38 more

Pharmacists closing health disparity gaps through pharmacogenomics

JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY(2022)10.1002/jac5.1629

N/A

0DataRank · unranked

0 citations

April Schultz, Philip E. Empey, Christine M. Formea

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy

Clinical and Translational Science(2021)10.1111/cts.13154

N/A

0DataRank · unranked

30 citations

Ramzi G. Salloum, Amanda L. Elchynski, D. Max Smith, Elizabeth J. Rowe, Kathryn Blake +24 more